abstract |
The present invention relates to the use of CYP2D6 inhibitors in combination with an active substance whose metabolism is catalyzed by CYP2D6 and wherein the active substance and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for use therein. SHE |